Summit Therapeutics SMMT Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's common stock shares issued?
- Summit Therapeutics (SMMT) reported common stock shares issued of 776M in Q1 2026.
- How has Summit Therapeutics's common stock shares issued changed year-over-year?
- Summit Therapeutics's common stock shares issued increased by 4.6% year-over-year, from 741.6M to 776M.
- What is the long-term trend for Summit Therapeutics's common stock shares issued?
- Over 5 years (2020 to 2025), Summit Therapeutics's common stock shares issued has grown at a 56.5% compound annual growth rate (CAGR), from 82.6M to 775.4M.